Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 310
Saving Women’s Lives: Strategies for Improving Breast Cancer Detection and Diagnosis
Appendix B
Workshop Agendas
NEW APPROACHES TO BREAST CANCER DETECTION (WORKSHOP #1)
National Academy of Sciences Building
Washington, DC
January 7, 2003
9:00
Welcome and Introduction
Ed Penhoet, Committee Chair
9:10
Overview of Current Options in Breast Cancer Detection
Laura Esserman, University of California San Francisco
9:40
Comparisons of Multiple Modalities: US, PET, MRI, Optical
Mitchell Schnall, University of Pennsylvania
10:10
Technical Advances in Mammography: Digital Mammography and DEI
Etta Pisano, University of North Carolina
10:40
Comparison of Four Breast Imaging Techniques
Keith Paulsen, Dartmouth
11:10
Computer Assisted Diagnosis
Maryellen Giger, University of Chicago
11:40
DISCUSSION
OCR for page 311
Saving Women’s Lives: Strategies for Improving Breast Cancer Detection and Diagnosis
12:00
LUNCH
12:45
Introduction to Tumor Markers
Jeff Marks, Duke University Medical Center
12:50
The Search for Breast Cancer Biomarkers
Sara Sukumar, Johns Hopkins Oncology Center
1:20
Deciphering the Molecular Signatures of Breast Cancer
Lance Liotta, Laboratory of Pathology, National Cancer Institute
1:50
Molecular Imaging
David Piwnica-Worms, Washington University
2:20
DISCUSSION
2:30
BREAK
2:45
Making Sense of the Mountains of Data: Bioinformatics and Breast Cancer Detection
Michael Vannier, National Cancer Institute/University of Iowa
3:15
SmartProbe: Spin-off Technology from NASA
Richard Hular, BioLuminate, Inc.
3:30
TransScan: Post-Script on a 1999 “Medical Breakthrough”
John Neugebauer, TransScan Medical, Inc.
3:45
Optical Scanning, Almost Approved
Phillip C. Thomas, DOBI, Inc.
4:00
DISCUSSION
4:15
WRAP-UP
4:45
ADJOURN
OCR for page 312
Saving Women’s Lives: Strategies for Improving Breast Cancer Detection and Diagnosis
FROM DEVELOPMENT TO ADOPTION OF NEW APPROACHES TO BREAST CANCER DETECTION AND DIAGNOSIS (WORKSHOP #2)
Keck Center of the National Academies
Washington, DC
February 18, 2003
9:00
Welcome and Introduction
Ed Penhoet, Committee Chair
9:10
Marketing Strategies: How Companies Work to Encourage Adoption of New Medical Technologies
Laura Shapiro, Siemens Medical Solutions
10:00
The Role of Innovative Not-for-Profits in Medical Innovation: Lessons from CaP CURE
Howard Soule, CaP CURE
10:50
The Role of Breast Cancer Philanthropies in Developing New Approaches to Breast Cancer Detection
Susan Braun, Susan G. Komen Foundation
11:40
DISCUSSION
3:00
ADJOURN
FROM DEVELOPMENT TO ADOPTION OF NEW APPROACHES TO BREAST CANCER DETECTION AND DIAGNOSIS (WORKSHOP #3)
National Academy of Sciences Building
Washington, DC
March 25, 2003
9:30
Welcome and Introduction
Ed Penhoet, Committee Chair
9:35
NCI Programs to Support Development of New Approaches to Breast Cancer Detection
Ed Staab, Branch Chief, Diagnostic Imaging, NCI
OCR for page 313
Saving Women’s Lives: Strategies for Improving Breast Cancer Detection and Diagnosis
10:15
Regulatory Challenges for In Vitro Diagnostics
Joseph Hackett, Special Projects Officer, Office of In Vitro Diagnostics, FDA
10:55
Challenges in Assessing the Safety and Efficacy of Cancer Detection Devices
David Feigal, Director, Center for Devices and Radiological Health, FDA
11:35
DISCUSSION
12:30
LUNCH
1:15
CMS Perspective on Adoption of New Breast Cancer Detection Technologies
Sean Tunis, Acting Chief Medical Officer, CMS
1:55
Private Health Payers’ Perspective on Adoption of New Breast Cancer Detection Technologies
Alan Rosenberg, Vice President of Medical and Credentialing Policy, WellPoint Health Networks
2:35
DISCUSSION
2:50
BREAK
3:10
Better Information and Decision Tools: The Needs of the Consumer
Mary Ropka, University of Virginia Medical School
3:50
Decision Support in Breast Cancer Detection Options: Health Systems Perspective
Nananda Col, Brigham & Women’s Hospital
4:30
DISCUSSION
4:45
ADJOURN
Representative terms from entire chapter:
cancer detection